연구동향 분석

eNOS3 Genetic Polymorphism Is Related to Post-Ablation Early Recurrence of Atrial Fibrillation

심재민 박희남 박재형 이지영 엄재선 정보영 이문형 Patrick T. Ellinor 2015년

논문상세정보
인용/피인용
' eNOS3 Genetic Polymorphism Is Related to Post-Ablation Early Recurrence of Atrial Fibrillation' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • atrial fibrillation
  • catheter ablation
  • enosgene
  • recurrence
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
7,789 0

0.0%

' eNOS3 Genetic Polymorphism Is Related to Post-Ablation Early Recurrence of Atrial Fibrillation' 의 참고문헌

  • The effect of electrogram duration on quantification of complex fractionated atrial electrograms and dominant frequency
    Stiles MK J Cardiovasc Electrophysiol 19 : 252 ~ 258 [2008]
  • The effect of electrogram duration on quantification of complex fractionated atrial electrograms and dominant frequency
    Stiles MK J Cardiovasc Electrophysiol 19 252-258 [2008]
  • The Glu298Asp polymorphism of the NOS 3gene as a determinant of the baseline production of nitric oxide
    Veldman BA J Hypertens 20 : 2023 ~ 2027 [2002]
  • The Glu298Asp polymorphism of the NOS 3gene as a determinant of the baseline production of nitric oxide
    Veldman BA J Hypertens 20 2023-2027 [2002]
  • Systematic review: comparative effectiveness of radiofrequency catheter ablation for atrial fibrillation
    Terasawa T Ann Intern Med 151 : 191 ~ 202 [2009]
  • Systematic review: comparative effectiveness of radiofrequency catheter ablation for atrial fibrillation
    Terasawa T Ann Intern Med 151 191-202 [2009]
  • Substrate and Trigger Ablation for Reduction of Atrial Fibrillation (STAR AF): a randomized, multicentre, international trial
    Verma A Eur Heart J 31 : 1344 ~ 1356 [2010]
  • Substrate and Trigger Ablation for Reduction of Atrial Fibrillation (STAR AF): a randomized, multicentre, international trial
    Verma A Eur Heart J 31 1344-1356 [2010]
  • Protracted CRP elevation after atrial fibrillation ablation
    McCabe JM Pacing Clin Electrophysiol 31 : 1146 ~ 1151 [2008]
  • Protracted CRP elevation after atrial fibrillation ablation
    McCabe JM Pacing Clin Electrophysiol 31 1146-1151 [2008]
  • Prevention of atrial fibrillation recurrence with corticosteroids after radiofrequency catheter ablation: a randomized controlled trial
    Koyama T J Am Coll Cardiol 56 : 1463 ~ 1472 [2010]
  • Prevention of atrial fibrillation recurrence with corticosteroids after radiofrequency catheter ablation: a randomized controlled trial
    Koyama T J Am Coll Cardiol 56 1463-1472 [2010]
  • Obesity phenotype and incident hypertension: a prospective community-based cohort study
    Lee SK J Hypertens 31 145-151 [2013]
  • Obesity phenotype and incident hypertension: A prospective communitybased cohort study
    Lee SK J Hypertens 31 : 145 ~ 151 [2013]
  • Long duration of radiofrequency energy delivery is an independent predictor of clinical recurrence after catheter ablation of atrial fibrillation: over 500 cases experience
    Shim J Int J Cardiol 167 : 2667 ~ 2672 [2013]
  • Long duration of radiofrequency energy delivery is an independent predictor of clinical recurrence after catheter ablation of atrial fibrillation: Over 500 cases experience
    Shim J Int J Cardiol 167 2667-2672 [2013]
  • Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298
    Tesauro M Proc Natl Acad Sci U S A 97 : 2832 ~ 2835 [2000]
  • Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298
    Tesauro M Proc Natl Acad Sci U S A 97 2832-2835 [2000]
  • Histopathologic effects of radiofrequency catheter ablation in previously infarcted human myocardium
    Grubman E J Cardiovasc Electrophysiol 10 : 336 ~ 342 [1999]
  • Histopathologic effects of radiofrequency catheter ablation in previously infarcted human myocardium
    Grubman E J Cardiovasc Electrophysiol 10 336-342 [1999]
  • HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation:recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation
    European Heart Rhythm Association (EHRA) Heart Rhythm 4 : 816 ~ 861 [2007]
  • HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation
    European Heart Rhythm Association (EHRA) Heart Rhythm 4 816-861 [2007]
  • Genetic susceptibility to atrial fibrillation in patients with congestive heart failure
    Bedi M Heart Rhythm 3 : 808 ~ 812 [2006]
  • Genetic susceptibility to atrial fibrillation in patients with congestive heart failure
    Bedi M Heart Rhythm 3 808-812 [2006]
  • Genetic mutations as risk predictors of atrial fibrillation recurrence after catheter ablation?
    Hall JL J Am Coll Cardiol 55 : 754 ~ 757 [2010]
  • Genetic mutations as risk predictors of atrial fibrillation recurrence after catheter ablation?
    Hall JL J Am Coll Cardiol 55 754-757 [2010]
  • Endothelial nitric oxide synthase gene polymorphism and ischemic heart disease
    Spence MS Am Heart J 148 : 847 ~ 851 [2004]
  • Endothelial nitric oxide synthase gene polymorphism and ischemic heart disease
    Spence MS Am Heart J 148 847-851 [2004]
  • Endothelial NO synthase gene polymorphisms and risk of ischemic stroke: a meta-analysis
    Tao HM Neurosci Res 64 : 311 ~ 316 [2009]
  • Endothelial NO synthase gene polymorphisms and risk of ischemic stroke: a meta-analysis
    Tao HM Neurosci Res 64 311-316 [2009]
  • Electrophysiologic characteristics of complex fractionated atrial electrograms in patients with atrial fibrillation
    Park JH J Cardiovasc Electrophysiol 20 : 266 ~ 272 [2009]
  • Electrophysiologic characteristics of complex fractionated atrial electrograms in patients with atrial fibrillation
    Park JH J Cardiovasc Electrophysiol 20 266-272 [2009]
  • Effects of sterile pericarditis on connexins 40 and 43 in the atria: correlation with abnormal conduction and atrial arrhythmias
    Ryu K Am J Physiol Heart Circ Physiol 293 : H1231 ~ H1241 [2007]
  • Effects of sterile pericarditis on connexins 40 and 43 in the atria: correlation with abnormal conduction and atrial arrhythmias
    Ryu K Am J Physiol Heart Circ Physiol 293 H1231-H1241 [2007]
  • Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation: potential mechanisms for atrial thrombosis and stroke
    Cai H Circulation 106 : 2854 ~ 2858 [2002]
  • Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation: potential mechanisms for atrial thrombosis and stroke
    Cai H Circulation 106 2854-2858 [2002]
  • Consistency of complex fractionated atrial electrograms during atrial fibrillation
    Lin YJ Heart Rhythm 5 : 406 ~ 412 [2008]
  • Consistency of complex fractionated atrial electrograms during atrial fibrillation
    Lin YJ Heart Rhythm 5 406-412 [2008]
  • Comparison of voltage map-guided left atrial anterior wall ablation versus left lateral mitral isthmus ablation in patients with persistent atrial fibrillation
    Pak HN Heart Rhythm 8 : 199 ~ 206 [2011]
  • Comparison of voltage map-guided left atrial anterior wall ablation versus left lateral mitral isthmus ablation in patients with persistent atrial fibrillation
    Pak HN Heart Rhythm 8 199-206 [2011]
  • Cardiac electrophysiological effects of nitric oxide
    Tamargo J Cardiovasc Res 87 : 593 ~ 600 [2010]
  • Cardiac electrophysiological effects of nitric oxide
    Tamargo J Cardiovasc Res 87 593-600 [2010]
  • Candidate gene polymorphisms for ischemic stroke
    Matarin M Stroke 40 : 3436 ~ 3442 [2009]
  • Candidate gene polymorphisms for ischemic stroke
    Matarin M Stroke 40 3436-3442 [2009]
  • C-reactive protein elevation in patients with atrial arrhythmias:inflammatory mechanisms and persistence of atrial fibrillation
    Chung MK Circulation 104 : 2886 ~ 2891 [2001]
  • C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation
    Chung MK Circulation 104 2886-2891 [2001]
  • Association of endothelial constitutive nitric oxide synthase gene polymorphism with acute coronary syndrome in Korean
    Park KW Heart 90 : 282 ~ 285 [2004]
  • Association of endothelial constitutive nitric oxide synthase gene polymorphism with acute coronary syndrome in Korean
    Park KW Heart 90 282-285 [2004]
  • Association of eNOS gene polymorphisms with essential hypertension in the Han population in southwestern China
    Li J Genet Mol Res 10 : 2202 ~ 2212 [2011]
  • Association of eNOS gene polymorphisms with essential hypertension in the Han population in southwestern China
    Li J Genet Mol Res 10 2202-2212 [2011]
  • Angiotensin-converting enzyme and endothelial nitric oxide synthase polymorphisms in patients with atrial fibrillation
    Gensini F Pacing Clin Electrophysiol 26 (1 Pt 2) : 295 ~ 298 [2003]
  • Angiotensin-converting enzyme and endothelial nitric oxide synthase polymorphisms in patients with atrial fibrillation
    Gensini F Pacing Clin Electrophysiol 26 1 Pt 2 295-298 [2003]
  • Analysis of minK and eNOS genes as candidate loci for predisposition to non-valvular atrial fibrillation
    Fatini C Eur Heart J 27 : 1712 ~ 1718 [2006]
  • Analysis of minK and eNOS genes as candidate loci for predisposition to non-valvular atrial fibrillation
    Fatini C Eur Heart J 27 1712-1718 [2006]
  • ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
    Fuster V Circulation 114 e257-e354 [2006]
  • ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001Guidelines for the Management of Patients With Atrial Fibrillation):developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
    Fuster V Circulation 114 : e257 ~ e354 [2006]
  • A pre-existent elevated C-reactive protein is associated with the recurrence of atrial tachyarrhythmias after catheter ablation in patients with atrial fibrillation
    Kurotobi T Europace 12 : 1213 ~ 1218 [2010]
  • A pre-existent elevated C-reactive protein is associated with the recurrence of atrial tachyarrhythmias after catheter ablation in patients with atrial fibrillation
    Kurotobi T Europace 12 1213-1218 [2010]
  • 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society
    Calkins H Heart Rhythm 9 : 632 ~ 696 [2012]
  • 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society
    Calkins H Heart Rhythm 9 632-696 [2012]